High definition spectral domain optical coherence tomography of retinal pigment epithelial rip in a case of sympathetic ophthalmia
ABSTRACT We are reporting a case of granulomatous panuveitis in the right eye following penetrating injury to the left eye.
A 34-year-old female was diagnosed to have sympathetic ophthalmia on treatment with systemic steroids. Vision did not improve in spite of aggressive systemic steroid therapy. On examination, patient had large retinal pigment epithelial rip nasal to the disc with exudative retinal detachment which was documented with FFA, ICG, and OCT. RPE rip is responsible for the persistent exudative retinal detachment in the right eye.
RPE rip can cause decreased vision due to persistence of retinal detachment in a case of sympathetic ophthalmia.
[Show abstract] [Hide abstract]
ABSTRACT: The purpose of this study was to describe the EDI-OCT findings in an acute phase of sympathetic ophthalmia (SO). A 24-year-old gentleman was referred to clinic complaining of progressive blurry vision of his right eye within last 3 days. He had a history of repaired corneoscleral laceration in his left eye followed by lensectomy and anterior vitrectomy approximately 1 month before his recent right eye discomfort. Physical examination revealed a granulomatous uveitis with an exudative RD of the right eye consistent with SO. EDI-OCT was done at initial exam and repeated 1 and 15 months after therapy. EDI-OCT 1 month following therapy showed significant improvement in choroidal thickening and outer retinal cell layers. The choroidal thickness in the right sympathizing eye decreased from 617 to 568 μm and in the left exciting eye from 539 to 521 μm. After 15 month follow-up, choroidal thickness that is reported in EDI-OCT is 436 μm in the right and 382 μm in the left eye. SO should be added to the list of choroidopathies that cause an increase in choroidal thickness in acute phase of disorder with subsequent decrease after therapy, so help us in assessing and estimation of response to treatment.International Ophthalmology 03/2015; 35(3). DOI:10.1007/s10792-015-0058-6 · 0.55 Impact Factor